Get Medevice Capital contact and information in

What is Medevice Capital?

Medevice Capital is a French venture capital fund specializing in the healthcare sector. Founded in 2011 by a team of entrepreneurs, the fund is focused on providing financial, strategic, and operational support to ambitious and innovative startups in the medtech and e-health industries.

Their investment strategy centers on early-stage companies with potential for strong growth and a clear impact on patient's lives. With a close relationship and hands-on approach, they work in unison with CEOs and co-founders, partaking in daily management and strategic decision-making.

The fund operates on a methodology developed internally that touches all vital aspects of a company, including R&D, market access, industrialization, human resources, commercial development, finance, non-dilutive financing, administrative support, and regulatory compliance. They prioritize investments in startups that address unmet needs in the medtech and digital health fields, with a particular focus on companies that demonstrate the possibility of reaching the market in less than three years. Medevice's seed investment ranges from 1 million to 1.5 million euros and can extend up to 4 million euros in a Series A round.

The underlying proposition of their investment thesis is that companies should have the technical capability and business model to achieve commercial success quickly. Testimonials from various CEOs in their portfolio echo the firm's effectiveness in contributing strategic and practical insights, underlining the dual role of Medevice Capital as both investor and executive. The fund actively cultivates a culture of entrepreneurial mindset, operational excellence, and trusting relationships.

These values have led to successful exits and have provided them with a diverse portfolio of startups, including Certis Therapeutics, Dyameo, Emagina, Pixyl, and several others. Their team comprises individuals with deep industry and research backgrounds, ensuring a knowledgeable partnership for the startups they invest in.